Bessemer Group Inc Repligen Corp Transaction History

Bessemer Group Inc

  • $60.7 Billion
  • Q3 2024

A detailed history of Bessemer Group Inc transactions in Repligen Corp stock. As of the latest transaction made, Bessemer Group Inc holds 255,191 shares of RGEN stock, worth $39.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
255,191
Previous 340,161 24.98%
Holding current value
$39.5 Million
Previous $42.9 Million 11.43%
% of portfolio
0.06%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$119.79 - $167.35 $10.2 Million - $14.2 Million
-84,970 Reduced 24.98%
255,191 $38 Million
Q2 2024

Aug 13, 2024
BUY
$120.0 - $182.95 $4.2 Million - $6.41 Million
35,025 Added 11.48%
340,161 $42.9 Million
Q1 2024

May 13, 2024
SELL
$170.78 - $208.42 $4.63 Million - $5.65 Million
-27,089 Reduced 8.15%
305,136 $56.1 Million
Q4 2023

Feb 09, 2024
BUY
$114.17 - $185.35 $2.32 Million - $3.77 Million
20,331 Added 6.52%
332,225 $59.7 Million
Q3 2023

Nov 13, 2023
BUY
$138.78 - $176.51 $2.23 Million - $2.83 Million
16,051 Added 5.43%
311,894 $49.6 Million
Q2 2023

Aug 10, 2023
BUY
$138.42 - $180.31 $1.49 Million - $1.93 Million
10,729 Added 3.76%
295,843 $41.9 Million
Q1 2023

May 10, 2023
BUY
$154.26 - $198.1 $632,157 - $811,813
4,098 Added 1.46%
285,114 $48 Million
Q4 2022

Feb 13, 2023
BUY
$162.42 - $220.56 $1.04 Million - $1.41 Million
6,408 Added 2.33%
281,016 $47.6 Million
Q3 2022

Nov 09, 2022
BUY
$160.42 - $256.21 $37.4 Million - $59.7 Million
233,116 Added 561.83%
274,608 $51.4 Million
Q2 2022

Aug 10, 2022
BUY
$140.68 - $188.02 $5.43 Million - $7.25 Million
38,577 Added 1323.4%
41,492 $6.74 Million
Q1 2022

May 12, 2022
BUY
$161.19 - $257.96 $19,020 - $30,439
118 Added 4.22%
2,915 $549,000
Q4 2021

Jan 27, 2022
BUY
$247.59 - $304.47 $247 - $304
1 Added 0.04%
2,797 $741,000
Q3 2021

Nov 12, 2021
BUY
$194.77 - $324.21 $201,781 - $335,881
1,036 Added 58.86%
2,796 $808,000
Q2 2021

Aug 06, 2021
SELL
$165.87 - $220.95 $57,059 - $76,006
-344 Reduced 16.35%
1,760 $352,000
Q1 2021

May 13, 2021
SELL
$180.37 - $226.26 $2,525 - $3,167
-14 Reduced 0.66%
2,104 $409,000
Q4 2020

Feb 09, 2021
BUY
$148.08 - $206.57 $7,404 - $10,328
50 Added 2.42%
2,118 $406,000
Q3 2020

Nov 12, 2020
SELL
$122.51 - $158.27 $1.32 Million - $1.71 Million
-10,803 Reduced 83.93%
2,068 $305,000
Q2 2020

Aug 05, 2020
BUY
$94.33 - $140.48 $1.21 Million - $1.8 Million
12,848 Added 55860.87%
12,871 $1.59 Million
Q3 2019

Nov 07, 2019
BUY
$76.65 - $95.51 $1,762 - $2,196
23 New
23 $2,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.59B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email